Taurine and Methylprednisolone Administration at Close Proximity to the Onset of Muscle Degeneration Is Ineffective at Attenuating Force Loss in the Hind-Limb of 28 Days Mdx Mice
An increasing number of studies have shown supplementation with the amino acid taurine to have promise in ameliorating dystrophic symptoms in the mdx mouse model of Duchenne Muscular Dystrophy (DMD). Here we build on this limited body of work by investigating the efficacy of supplementing mdx mice w...
Main Authors: | Robert G. Barker, Chris van der Poel, Deanna Horvath, Robyn M. Murphy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Sports |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4663/6/4/109 |
Similar Items
-
Arginine butyrate per os protects mdx mice against cardiomyopathy, kyphosis and changes in axonal excitability
by: Sara Vianello, et al.
Published: (2014-11-01) -
l-arginine improves dystrophic phenotype in mdx mice
by: Vincent Voisin, et al.
Published: (2005-10-01) -
Development of a SNP Assay for the Differentiation of Allelic Variations in the mdx Dystrophic Mouse Model
by: Misyak, Sarah A.
Published: (2014) -
Accelerating the <i>Mdx</i> Heart Histo-Pathology through Physical Exercise
by: Jacopo Morroni, et al.
Published: (2021-07-01) -
Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice
by: Hannah G. Radley, et al.
Published: (2006-08-01)